Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Rocket Pharmaceuticals Inc shares valued at $5,139 were sold by Militello John on Apr 22 ’25. At $7.16 per share, Militello John sold 718 shares. The insider’s holdings dropped to 65,039 shares worth approximately $0.46 million following the completion of this transaction.
Also, Militello John purchased 718 shares, netting a total of over 5,140 in proceeds.
Before that, Shah Gaurav had added 20,000 shares to its account. In a trade valued at $101,600, the CEO bought Rocket Pharmaceuticals Inc shares for $5.08 each. Upon closing the transaction, the insider’s holdings increased to 20,000 shares, worth approximately $5.58 million.
As published in their initiating research note from BMO Capital Markets on March 12, 2025, Rocket Pharmaceuticals Inc [RCKT] has been an Outperform and the price target has been revised to $50. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in late December. As of December 18, 2024, Jefferies has initiated its “Buy” rating for RCKT. Earlier on October 16, 2024, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for RCKT stock.
Analyzing RCKT Stock Performance
During the last five days, there has been a drop of approximately -10.43%. Over the course of the year, Rocket Pharmaceuticals Inc shares have dropped approximately -43.99%. Shares of the company reached a 52-week high of $13.35 on 01/02/25 and a 52-week low of $4.55 on 04/09/25. A 50-day SMA is recorded $7.41, while a 200-day SMA reached $13.57.
Support And Resistance Levels for Rocket Pharmaceuticals Inc (RCKT)
According to the 24-hour chart, there is a support level at 6.73, which, if violated, would cause prices to drop to 6.42. In the upper region, resistance lies at 7.32. The next price resistance is at 7.60. RSI (Relative Strength Index) is 49.38 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.59, which suggests the price will decrease in the coming days. Percent R is at 59.51%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
